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Purpose: A task force appointed by the Korean Society of Acute Care Surgery reviewed previously published guidelines on 
antibiotic use in patients with abdominal injuries and adapted guidelines for Korea. 
Methods: Four guidelines were assessed using the Appraisal of Guidelines for Research and Evaluation II instrument. Five 
topics were considered: indication for antibiotics, time until first antibiotic use, antibiotic therapy duration, appropriate 
antibiotics, and antibiotic use in abdominal trauma patients with hemorrhagic shock. 
Results: Patients requiring surgery need preoperative prophylactic antibiotics. Patients who do not require surgery do not 
need antibiotics. Antibiotics should be administered as soon as possible after injury. In the absence of hollow viscus injury, 
no additional antibiotic doses are needed. If hollow viscus injury is repaired within 12 hours, antibiotics should be continued 
for ≤ 24 hours. If hollow viscus injury is repaired after 12 hours, antibiotics should be limited to 7 days. Antibiotics can 
be administered for ≥7 days if hollow viscus injury is incompletely repaired or clinical signs persist. Broad-spectrum 
aerobic and anaerobic coverage antibiotics are preferred as the initial antibiotics. Second-generation cephalosporins are 
the recommended initial antibiotics. Third-generation cephalosporins are alternative choices. For hemorrhagic shock, the 
antibiotic dose may be increased twofold or threefold and repeated after transfusion of every 10 units of blood until there is 
no further blood loss. 
Conclusion: Although this guideline was drafted through adaptation of other guidelines, it may be meaningful in that it 
provides a consensus on the use of antibiotics in abdominal trauma patients in Korea.
[Ann Surg Treat Res 2019;96(1):1-7]
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INTRODUCTION
Surgical site infection is a common complication after ab dom-
inal trauma and is associated with an increase in morbidity, 
mortality, and hospital stay, and the appropriate use of 
antibiotics for abdominal trauma is essential in decreasing 
surgical site infection. However, in the absence of a hollow-
viscus injury, no additional antibiotics are warranted. In 
add ition, the overuse of antibiotics is problematic, because 
systemic inflammatory response syndrome due to injury is 
often mistaken for infection in the acute phase. Therefore, it is 
essential for clinicians to have a guideline regarding antibiotic 
use in patients with abdominal trauma.
Since 2012, the Korean government has implemented a na tion-
al trauma system including 17 level I trauma centers. Evidence-
based protocol-driven care can ensure optimal comprehensive 
care for injured patients, but a lack of consensus regarding 
trauma management is problematic. In particular, there are 
limited data supporting the use of antibiotics for patients with 
abdominal trauma. Although the Eastern Association for the 
Surgery of Trauma (EAST) practice management guideline (PMG) 
was published in 2012, the recommendations were made only 
for patients with penetrating abdominal trauma [1]. Therefore, 
the Korean Society of Acute Care Surgery (KSACS) developed 
the Korean guideline for antibiotic use in abdominal trauma 
patients. The purpose of this guideline is to evaluate and adapt 
previous guidelines of antibiotic use in abdominal trauma 
through the guideline adaptation method using the Appraisal of 
Guidelines for Research and Evaluation (AGREE) II instrument 
[2].
These guidelines target trauma patients with abdominal 
injury, including abdominal penetrating injury as well as blunt 
injury, and were designed for trauma surgeons and emergency 
medicine doctors, who make the initial decision to administer 
antibiotics. Detailed information about antibiotic use will pro-
mote the understanding of infection prevention and control 
in trauma patients by other clinicians who work within 
multidisciplinary team settings, including infection specialists 
and nurses who care for trauma patients. 
METHODS
Organization of the committee
In 2014, the KSACS appointed a task force to develop practice 
management guidelines. This task force included members of 
the clinical research committee, as well as general surgeons 
from regional trauma centers. The purpose of this project was 
to develop practice guidelines for antibiotic use in abdominal 
trauma patients.
Selection of key questions
The task force divided topics of consideration into 5 cate-
gories: indication for antibiotic use, time to first antibiotic use, 
duration of antibiotic therapy, appropriate antibiotics, and 
anti biotic use in abdominal trauma patients with hemorrhagic 
shock. Key questions to be addressed were formulated for each 
category. The selected key questions are listed in Table 1. 
Literature search and quality assessment
The task force searched guidelines published until 2014 
about antibiotic use for abdominal trauma patients through 
MEDLINE, Embase, and GIN (Guideline International Net-
Table 1. Recommendation summary
Key question Recommendation
Who is indicated for antibiotic 
therapy?
1. Patients requiring surgery should be administered preoperative prophylactic antibiotics. 
(1A)
2. Patients not requiring surgery should not be administered antibiotics. (1A)
When should antibiotics be started? 3. Antibiotics should be administrated as soon as possible after injury. (1C)
How long should antibiotic therapy 
be administrated in abdominal 
trauma?
4. In the absence of hollow viscus injury, no additional doses of antibiotics are needed. (1A)
5. If hollow viscus injury is repaired within 12 hours, antibiotics should be continued for no 
more than 24 hours. (1A)
6. If hollow viscus injury is repaired after 12 hours, antibiotics should be limited to 7 days. 
(2C)
7. Antibiotics can be administered for more than 7 days if hollow viscus injury is 
incompletely repaired or clinical signs persist. (2C)
What are the appropriate antibiotics? 8. Broad-spectrum aerobic and anaerobic coverage antibiotics are preferred as initial 
antibiotics. (1A) 
9. Second generation cephalosporin are the recommended initial antibiotics. (1B)
10. Third generation cephalosporins can be an alternative choice. (2B)
How should antibiotic therapy be 
modified for patients with 
hemorrhagic shock?
11. In patients admitted with hemorrhagic shock, the administered dose of antibiotics may 
be increased twofold or threefold and repeated after transfusion of every 10 units of 
blood until there is no further blood loss. (2B)
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work). The keywords used were antibiotics, intra-abdominal 
infection, intra-abdominal injury, trauma, panperitonitis, 
and abdominal trauma. Finally, four guidelines [1,3-5] were 
selected and assessed by the AGREE II instrument [2]. Nine 
committee members evaluated the quality of these guidelines 
according to 23 steps of the AGREE II instrument. In consensus 
meetings and using recommendations of these four guidelines, 
committee members developed new guidelines concerning 
each key question. 
Strength of recommendations and grade of 
evidence
The GRADE system was adopted in the present guidelines 
after review and revision by the committee members. This 
system uses 2 basic levels of recommendation (strong and weak) 
and four levels of evidence (high-quality, moderate-quality, low-
quality, or very low-quality) (Table 2) [6]. 
RESULTS
I. Who is indicated for antibiotic therapy?
Recommendations
1. Patients who require surgery should be administered 
preoperative prophylactic antibiotics. (1A) 
2. Patients who do not require surgery should not be 
administered antibiotics. (1A)
Evidence summary
The 2012 EAST PMG was the only guideline to address 
whether antibiotic administration was necessary in patients 
with abdominal trauma [1]. The mortality rate was reported 
as 65%–70% in the 1910s when antibiotics were not used after 
abdominal surgery [7]. In 1998, the EAST PMG committee 
reviewed 39 articles and recommended that single broad-spec-
trum antibiotics should be used in patients with penetrating 
abdominal trauma, and no additional dose of prophylactic 
antibiotic was needed in the absence of viscus perforation. Be-
cause it was reported that use of antibiotics with anaerobic 
coverage reduced postoperative infections, the 2000 EAST PMG 
recommended that prophylactic antibiotics to cover anaerobic 
organisms should be administered to patients with penetrating 
abdominal injury [8,9]. The 2000 EAST PMG noted that there 
was no comparative blind study on whether to use antibiotics 
for penetrating abdominal wounds, because of ethical issues 
caused by high mortality and morbidity rates in patients who 
were not administered antibiotics [9]. Therefore, the use of 
anti biotics in patients with penetrating wounds is considered 
standard. Most previous studies of prophylactic antibiotics have 
targeted patients with penetrating injuries, and this seems to 
be the reason prophylactic antibiotics are used primarily in 
patients undergoing surgery. However, emergency laparotomy 
is not always performed in patients with blunt trauma, and in 
these cases, antibiotics are not generally used. Therefore, there 
is no evidence concerning the use of prophylactic antibiotics 
for patients with abdominal blunt trauma who do not require 
surgery. 
II. When should antibiotics be started?
Recommendation
Antibiotics should be administrated as soon as possible after 
injury. (1C)
Evidence summary
The only practice guideline to address the best timing 
of antibiotics administration was the 2012 EAST PMG [1]. 
Burke et al. [10] and Alexander et al. [11] performed animal 
research on the relationship between the timing of antibiotic 
administration and the incidence of staphylococcus infection, 
and reported that the therapeutic effect was greatest in the 
group administered antibiotics within 3 hours of the bacterial 
injection, especially when a therapeutic blood antibacterial 
level was reached before bacterial injection. This became 
the backbone study for the proposition that the earliest 
antimicrobial administration is the most effective to prevent 
surgical site infection. Fullen et al. [12] retrospectively analyzed 
295 patients with abdominal penetrating injury to confirm the 
correlation between the occurrence of skin and intra-abdominal 
abscess and the timing of antimicrobial administration 
(preoperative, intraoperative, and postoperative groups), and 
showed that the preoperative group had a significantly lower 
infection rate than the other two groups (7% vs. 33% and 30%, 
respectively). Although there have been no other studies about 
this issue in abdominal trauma patients, the application of the 
same principle of antibiotic use is notable, and various studies 
Ji Young Jang, et al: Antibiotic use in abdominal trauma patients




  1 Strong recommendation
  2 Weak recommendation
Quality of evidence
  A RCT
  B Downgraded RCT or upgraded observational 
studies
  C Well-done observational studies with control 
RCTs
  D Downgraded controlled studies or expert 
opinion based on other evidence
RCT, randomized controlled trial. 
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have reported that the early administration of antibiotics 
for complex and open extremity injuries reduced infectious 
complications [13]. Therefore, if emergent abdominal surgery is 
necessary, antibiotics should be administered preoperatively. 
In patients with intra-abdom inal infection due to abdominal 
trauma, antibiotics should be started as soon as possible with 
identification of the contam ination [4,5]. 
III.  How long should antibiotic therapy be 
administered in abdominal trauma?
Recommendations
1. In the absence of hollow viscus injury, no additional doses 
of antibiotics are needed. (1A)
2. If hollow viscus injury is repaired within 12 hours, anti-
biotics should be continued for no more than 24 hours. (1A)
3. If hollow viscus injury is repaired after 12 hours, antibiotics 
should be limited to 7 days. (2C)
4. Antibiotics can be used for more than 7 days if hollow 
viscus injury is incompletely repaired or clinical signs persist in 
patients with traumatic abdominal injury. (2C) 
Evidence summary
The EAST PMG committee reviewed articles from 1976 
to 1997, and published PMG for prophylactic antibiotic use 
in penetrating abdominal trauma in 1998 [9]. Among these 
articles, Fabian et al. [14] reported a randomized controlled 
study that enrolled 515 patients in 1992, and showed that there 
was no major infection among 280 patients without hollow 
viscus perforation in spite of the preoperative single admin-
istration of prophylactic antibiotics. This study became the 
evidence that single prophylactic antibiotics should be used in 
abdominal trauma without viscus injury.
A number of studies have assessed the duration of antibiotic 
use, and the 1998 EAST PMG recommended that prophylactic 
antibiotics for penetrating abdominal injury should be used 
within 24 hours in the presence of hollow viscus injury [9,14-16]. 
Later, Kirton et al. [17] compared a 24-hour course and a 5-day 
course of ampicillin/sulbactam in a prospective randomized 
double-blind placebo-controlled study. It was confirmed 
that there was no significant difference in the infection rate 
between the 2 groups, and this became additional evidence 
of antibiotic use within 24 hours. The 2012 EAST guideline 
was updated with further research [1]. The guidelines for 
the prevention of infections associated with combat-related 
injury was published by the Infectious Disease Society of 
America (IDSA) and Surgical Infection Society (SIS) in 2011, and 
recommended that antibiotics be administered in penetrating 
abdominal injury with suspected or known viscus injury and 
soilage for 24 hours after prompt definitive washout [3,14,18]. 
According to the 2010 IDSA-SIS guideline for complicated 
intra-abdominal infection, if hollow viscus injury caused by 
penetrating, blunt, and iatrogenic trauma is repaired within 
12 hours, antibiotics should be administered within 24 hours, 
and if the injury is repaired after 12 hours, antibiotics could be 
administered during 4–7 days [4,19,20]. These results indicate 
that short-term antibiotic use is not appropriate in patients 
with infection beyond the initial site or in patients with a 
large amount of intra-abdominal infected fluid; instead of con-
sidering prophylactic antibiotic treatment for these patients, 
they should be treated with antibiotics according to established 
peritonitis treatment [20]. 
IV. What are the appropriate antibiotics?
Recommendations 
1. Broad-spectrum aerobic and anaerobic coverage antibiotics 
are preferred as initial antibiotics. (1A) 
2. Second generation cephalosporins are recommended as ini-
tial antibiotics. (1B)
3. Third generation cephalosporins are alternative choices. 
(2B)
Evidence summary
Several guidelines for prophylactic antibiotic use in patients 
with abdominal injury have emphasized broad-spectrum anti-
biotics to cover aerobic and anaerobic organisms [1,3,8]. In a 
randomized controlled trial in 1973, the kanamycin/cephalothin 
and the kanamycin/clindamycin regimens were compared. 
The kanamycin/clindamycin group, in which clindamycin was 
used for coverage of anaerobic bacteria, had a significantly 
lower infection rate than the kanamycin/cephalothin group 
(10% vs. 27%). This difference was caused by infection rates by 
anaerobic bacteria, which occurred in 2% of the clindamycin 
group and 21% of the cephalothin group [8]. The guidelines for 
the prevention of infections associated with combat-related 
injury recommended that the selected antibiotics should be 
effective for all predictable bacteria, able to cover all wound 
sites, and have a narrow spectrum [3]. Colon injury has the 
high est intra-abdominal infection rate, and anaerobic bacteria 
is most frequently isolated, which is identified 1,000–10,000 
times more frequently than aerobic organisms [15]. 
Escherichia coli is the most common anaerobic bacteria, and 
it and Bacteroides fragilis occupy 20%–30% of stool weight. 
These 2 organisms are the most common sources of surgical 
site infection after colon surgery. Condon et al. [21] reported 
that the rate of surgical site infection was 39%, because the first 
generation cephalosporin used as prophylactic antibiotic was 
not effective against anaerobic bacteria such as B. fragilis. For 
this reason, exclusive use of first generation cephalosporins 
is not effective as prophylactic antibiotic, and antibiotics to 
cover anaerobic bacteria are essential in cases of colon injury. 
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Hofstetter et al. [22] compared the combination of amino-
glycoside, ampicillin, and clindamycin with cefoxitin alone 
in 119 patients who underwent abdominal surgery due to 
trau matic injury, and reported that the rates of surgical site 
infection were similar in both groups (12% vs. 13%), indicating 
that the exclusive use of second generation cephalosporin was 
possible in these patients. The 2012 Surviving Sepsis Campaign 
guideline recommended that empiric broad-spectrum 
antibiotics should be generally administered to patients 
with severe sepsis, and combination antibiotic therapy could 
also be used [23]. However, compared with mono-antibiotic 
therapy, combination therapy in severe trauma patients had 
no additional benefit in the mortality rate and increased the 
risk of antibiotic resistance [18]. The risk of infection increased 
in an ‘S’ shape depending on the degree of injury in severe 
trau ma patients, and longer use of prophylactic antibiotics 
might be required in these patients [24]. Additionally, mono-
therapy with ertapenem, which was approved by U.S. Food 
and Drug Administration, had the same or superior efficacy in 
elective colon surgery compared to other combination therapy 
[25]. Moxifloxacin also showed equivalent efficacy with other 
combination therapies in patients with complicated intra-
abdominal infection [26]. In addition, several meta-analyses 
comparing combination therapy with aminoglycosides and 
mono-therapy with beta lactam antibiotics reported that the 
addition of aminoglycoside had no additional benefit [15]. 
Although there have been no one-to-one comparative studies 
between second generation and third generation cepha lo-
sporins, when third generation cephalosporin was used, the 
rate of surgical site infection in elective colon surgery was 
8%–19%. In addition, second generation cephalosporins were 
recommended as preoperative antibiotics for elective colon 
surgery [27], and as the basic antibiotic in combination therapy 
for complicated intra-abdominal infection [4,19]. If resistance to 
first or second generation cephalosporins increases gradually 
in hospitals, use of third generation cephalosporins is recom-
mended. However, antibiotic resistance due to the general 
use of third and fourth generation cephalosporins should be 
seriously considered [28]. Prophylactic antibiotics should be 
selected according to the prevalence of antibiotic resistance in 
respective hospitals.
V.  How should antibiotic therapy be modified for 
patients with hemorrhagic shock?
Recommendation
1. In patients admitted with hemorrhagic shock, the admin-
istered dose of antibiotics may be increased twofold or threefold 
and repeated after transfusion of every 10 units of blood until 
there is no further blood loss. (2B)
Evidence summary
Because of vasoconstriction and decrease of antibiotic trans-
portation to peripheral tissues in patients with hemor rhagic 
shock, administration of an additional dose of prophylactic 
anti biotic is recommended [1]. In a study of 150 patients with 
abdominal trauma, Ericsson at al. [16] concluded that the 
use of high-dose amikacin significantly reduced infection in 
patients with a large amount of hemorrhage, and the infection 
rate was increased in trauma patients with a subtherapeutic 
blood level of antibiotics. This was the only study with a 
recommendation about antibiotic use in hemorrhagic shock, 
so the recommendation level is only 2B. The guidelines for the 
prevention of infections associated with combat-related injury 
in 2011 recommended that prophylactic antibiotics should be 
administered again in patients who undergo large transfusions 
(1,500–2,000 mL of hemorrhage) regardless of the timing of 
first administration [3]. However, that guideline was supported 
by not studies of spine and hip trauma rather than abdominal 
trauma [29,30]. Therefore, more evaluation will be needed to 
apply this recommendation to the present guideline, because of 
insufficient evidence in abdominal trauma patients. 
CONCLUSION
This guideline will be updated by the clinical research 
committee of the KSACS every 5 years. Although this 
guideline was made by adaptation of other guidelines, it may 
be meaningful in that it provides a consensus on the use of 
antibiotics in abdominal trauma patients in Korea. 
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